Literature DB >> 19198021

Dynamic measurements of serum inhibin B and estradiol: a predictive evaluation of ovarian response to gonadotrophin stimulation in the early stage of IVF treatment.

Ming-fang Miao1, He-feng Huang.   

Abstract

OBJECTIVE: We dynamically measured serum inhibin B and estradiol in the early stage of hormonal stimulation to predict the ovarian response in in vitro fertilization (IVF) treatment.
METHODS: A total of 57 patients (<40 years of age) who underwent the first cycle of long protocol IVF or introcytoplasmic sperm injection (ICSI) treatment were included. Serum inhibin B, estradiol, follicle stimulating hormone (FSH) and luteinizing hormone (LH) levels were measured four times: (1) on Day 3 of the menstrual cycle (basal); (2) on the day before the first administration of gonadotrophin (Gn) (Day 0); (3) on Day 1 of Gn therapy; and (4) on Day 5 of Gn therapy. Comparisons of these measurements with ovarian responses and pregnancy outcomes were made and analyzed statistically.
RESULTS: (1) On Day 1 and Day 5 of recombinant FSH (rFSH) stimulation, ovarian response, i.e., numbers of follicles, oocytes, fertilized oocytes, and embryos, had a positive correlation (r(s)=0.46~0.61, P=0.000) with raised inhibin B and estradiol concentrations, but a negative correlation (r(s)=-0.67~-0.38, P=0.000 or P<0.01) with total rFSH dose and total days of rFSH stimulation. (2) No significant variation (P>0.05) between the pregnant and non-pregnant groups on the basis of mean age or on all hormone concentrations at four times of the IVF cycle was observed. However, all the seven patients aged >35 years did not reach pregnancy.
CONCLUSIONS: (1) Serum inhibin B and estradiol concentrations obtained shortly after Gn therapy may offer an accurate and early prediction of ovarian response; (2) Low levels of serum inhibin B and estradiol obtained shortly after Gn stimulation indicate the need for a longer period of Gn treatment and a higher daily dosage; (3) No obvious pregnancy difference among patients of age <35 years was found; however, IVF pregnancy outcome is significantly lower in women of age >35 years.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19198021      PMCID: PMC2613961          DOI: 10.1631/jzus.B0820029

Source DB:  PubMed          Journal:  J Zhejiang Univ Sci B        ISSN: 1673-1581            Impact factor:   3.066


  45 in total

1.  Dynamic assays of inhibin B and oestradiol following buserelin acetate administration as predictors of ovarian response in IVF.

Authors:  A Ravhon; S Lavery; S Michael; M Donaldson; R Margara; G Trew; R Winston
Journal:  Hum Reprod       Date:  2000-11       Impact factor: 6.918

2.  An analysis of the effect of age on implantation rates.

Authors:  S D Spandorfer; P H Chung; I Kligman; H C Liu; O K Davis; Z Rosenwaks
Journal:  J Assist Reprod Genet       Date:  2000-07       Impact factor: 3.412

3.  Simultaneous evaluation of basal FSH and oestradiol response to GnRH analogue (F-G-test) allows effective drug regimen selection for IVF.

Authors:  D M Ranieri; P Phophong; I Khadum; F Meo; C Davis; P Serhal
Journal:  Hum Reprod       Date:  2001-04       Impact factor: 6.918

4.  Day 5 inhibin B serum concentrations as predictors of assisted reproductive technology outcome in cycles stimulated with gonadotrophin-releasing hormone agonist-gonadotrophin treatment.

Authors:  J Peñarrubia; J Balasch; F Fábregues; F Carmona; R Casamitjana; V Moreno; J M Calafell; J A Vanrell
Journal:  Hum Reprod       Date:  2000-07       Impact factor: 6.918

5.  Inhibin-B as a test of ovarian reserve for infertile women.

Authors:  S L Corson; J Gutmann; F R Batzer; H Wallace; N Klein; M R Soules
Journal:  Hum Reprod       Date:  1999-11       Impact factor: 6.918

6.  [Effect of blood concentrations of preovulatory estradiol on the quality of eggs and pre-embryos in patients treated with fertilization in vitro].

Authors:  A Kably Ambe; J Barrón Vallejo; R C Tapia Lizárraga; S K Krivitsky
Journal:  Ginecol Obstet Mex       Date:  2000-11

7.  Evaluation of basal estradiol levels in assisted reproductive technology cycles.

Authors:  J L Frattarelli; P A Bergh; M R Drews; F I Sharara; R T Scott
Journal:  Fertil Steril       Date:  2000-09       Impact factor: 7.329

8.  The prognostic value of age and follicle-stimulating hormone levels in women over forty years of age undergoing in vitro fertilization.

Authors:  A H Watt; A T Legedza; E S Ginsburg; R L Barbieri; R N Clarke; M D Hornstein
Journal:  J Assist Reprod Genet       Date:  2000-05       Impact factor: 3.412

9.  Inhibin B response to EFORT is associated with the outcome of oocyte retrieval in the subsequent in vitro fertilization cycle.

Authors:  A Dzik; G Lambert-Messerlian; V M Izzo; J B Soares; J A Pinotti; D B Seifer
Journal:  Fertil Steril       Date:  2000-12       Impact factor: 7.329

10.  Ovarian reserve test with human menopausal gonadotropin as a predictor of in vitro fertilization outcome.

Authors:  F Fábregues; J Balasch; M Creus; F Carmona; B Puerto; L Quintó; R Casamitjana; J A Vanrell
Journal:  J Assist Reprod Genet       Date:  2000-01       Impact factor: 3.412

View more
  1 in total

1.  Can Inhibin B Reflect Ovarian Reserve of Healthy Reproductive Age Women Effectively?

Authors:  Jingyi Wen; Kecheng Huang; Xiaofang Du; Hanwang Zhang; Ting Ding; Cuilian Zhang; Wenmin Ma; Ying Zhong; Wenyu Qu; Yi Liu; Zhiying Li; Song Deng; Aiyue Luo; Yan Jin; Jinjin Zhang; Shixuan Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-14       Impact factor: 5.555

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.